Becton Dickinson and Co vs Shell PLC — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while Shell PLC trades at $90.25 (market cap $250.44B). The key difference: Shell PLC is far larger — about 5.1× Becton Dickinson and Co's market cap, and Shell PLC pays the higher dividend (3.45%). Which is the better fit depends on your goals.
| BDX | SHEL | |
|---|---|---|
Market Cap | $49.41B | $250.44B |
Sector | Health | Energy |
52-Week High | $185.39 | $94.15 |
52-Week Low | $138.62 | $70.31 |
Enterprise Value | $65.51B | $292.14B |
Dividend Yield | 2.32% | 3.45% |
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →